Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.

Samankaltaisia teoksia

• Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
  Tekijä: Chintu, C, et al.
  Julkaistu: (2004)
• The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
  Tekijä: Walker, A, et al.
  Julkaistu: (2007)
• Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
  Tekijä: Walker, A, et al.
  Julkaistu: (2009)
• Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
  Tekijä: Haberer, J, et al.
  Julkaistu: (2011)
• Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.
  Tekijä: Jessica E Haberer, et al.
  Julkaistu: (2011-04-01)